Ligand validation:3HXU

HED: 2-HYDROXYETHYL DISULFIDE

HED is a Ligand Of Interest in 3HXU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HXU_HED_A_443	28%	67%	0.169	0.819	0.49	0.77	-	-	0	0	100%	1
3HXZ_HED_A_445	71%	81%	0.118	0.937	0.27	0.54	-	-	3	0	100%	1
3HY0_HED_B_444	61%	71%	0.142	0.932	0.28	0.83	-	-	2	0	100%	1
3HXW_HED_A_446	53%	90%	0.154	0.916	0.25	0.34	-	-	0	0	100%	1
3HXV_HED_A_443	41%	60%	0.174	0.891	0.48	1.02	-	-	0	0	100%	1
3HY1_HED_A_443	20%	73%	0.234	0.839	0.28	0.74	-	-	0	0	100%	1
1QSQ_HED_A_170	99%	67%	0.052	0.98	0.4	0.85	-	-	3	0	100%	1
1LWG_HED_A_901	96%	75%	0.065	0.973	0.43	0.56	-	-	0	0	100%	1
1QUG_HED_A_170	88%	68%	0.089	0.964	0.52	0.7	-	-	0	0	100%	0.5625
244L_HED_A_170	87%	60%	0.075	0.945	0.4	1.11	-	1	2	0	100%	1
1QS5_HED_A_170	85%	70%	0.121	0.988	0.39	0.76	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.